Detalhe da pesquisa
1.
Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice.
Int J Clin Oncol
; 25(5): 899-905, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907720
2.
TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer.
Transl Oncol
; 14(1): 100918, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33129110